TP53 and gastric cancer: In gastric cancers, overexpression of p53 is strongly linked to its mutational status, also correlating to resistance to cisplatin [6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46].